| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |